CRANE STRATEGIES

Lobbying for SIGA TECHNOLOGIES · Pharmaceutical

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $80,000.00 income · posted May 4, 2026

Lobbying activity 1

Budget/Appropriations

Biodefense funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem